Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...

A new study has found that lung cancer tumors 'feed' off sugar and shed light on the link between diet and the disease.

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led ...

After being used since the 1940s in various industries, asbestos is now linked to severe health risks, including asbestosis, ...

NEIGHBOURS veteran Ian Smith has given an update on his health after being diagnosed with terminal cancer in December. The ...

A York County business owner is sharing his story of hope after completing an innovative cancer treatment at WellSpan York Hospital. John Grim has been battling prostate cancer for nearly seven ...